Preclinical characterization of ALG-031048, a novel STING agonist with potent anti-tumor activity in mice

被引：7
|
作者：
Jekle, Andreas [1 ]
Thatikonda, Santosh [1 ]
Stevens, Sarah [1 ]
Williams, Caroline [1 ]
Kinkade, April [1 ]
Ren, Suping [1 ]
Jaisinghani, Ruchika [1 ]
Zhang, Qingling [1 ]
Misner, Dinah [1 ]
Stoycheva, Antitsa [1 ]
Deval, Jerome [1 ]
Mukherjee, Sucheta [1 ]
Gonzalvez, Francois [2 ]
Chanda, Sushmita [1 ]
Smith, David B. [1 ]
Symons, Julian A. [1 ]
Blatt, Lawrence M. [1 ]
Beigelman, Leonid [1 ]
机构：
[1] Aligos Therapeut, San Francisco, CA USA
[2] Aligos Belgium, Leuven, Belgium
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-4520
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4520
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Preclinical characterization of GSK532, a novel STING agonist with potent anti-tumor activity
    Yang, Jingsong
    Adam, Michael
    Clemens, Jim
    Creech, Katrina
    Schneck, Jess
    Pasikanti, Kishore
    Jean-Luc Tran
    Joglekar, Devika
    Hopson, Chris
    Pesiridis, Scott
    Ramanjulu, Joshi
    Lian, Yiqian
    Adams, Jerry L.
    Smothers, James
    Hoos, Axel
    CANCER RESEARCH, 2018, 78 (13)
  • [2] TUMOR REGRESSION IN A MOUSE MODEL OF HEPATOCELLULAR CARCINOMA UPON TREATMENT WITH THE STING AGONIST ALG-031048
    Jekle, Andreas
    Thatikonda, Santosh
    Jaisinghani, Ruchika
    Ren, Suping
    Mukherjee, Sucheta
    Chanda, Sushmita
    Symons, Julian A.
    Blatt, Lawrence M.
    Beigelman, Leonid N.
    Gonzalvez, Francois
    HEPATOLOGY, 2020, 72 : 675A - 675A
  • [3] Tumor Regression upon Intratumoral and Subcutaneous Dosing of the STING Agonist ALG-031048 in Mouse Efficacy Models
    Jekle, Andreas
    Thatikonda, Santosh Kumar
    Jaisinghani, Ruchika
    Ren, Suping
    Kinkade, April
    Stevens, Sarah K.
    Stoycheva, Antitsa
    Rajwanshi, Vivek K.
    Williams, Caroline
    Deval, Jerome
    Mukherjee, Sucheta
    Zhang, Qingling
    Chanda, Sushmita
    Smith, David B.
    Blatt, Lawrence M.
    Symons, Julian A.
    Gonzalvez, Francois
    Beigelman, Leonid
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [4] Preclinical characterization of a novel non-cyclic dinucleotide small molecule STING agonist with potent antitumor activity in mice
    Wang, Zezhou
    Dove, Peter
    Rosa, David
    Bossen, Bolette
    Helke, Simone
    Charbonneau, Marilyse
    Brinen, Laura
    Dodge, Karen
    Lin, Gloria H.
    Galligan, Carole
    Viller, Natasja N.
    Wong, Mark
    Lee, Vivian
    Catalano, Tina
    Uger, Robert A.
    Slassi, Malik
    Winston, Jeff
    CANCER RESEARCH, 2019, 79 (13)
  • [5] Discovery of novel STING agonists with robust anti-tumor activity
    Li, Anrong
    Song, Yuntao
    Dong, Chen
    Chen, Xiaoqi
    Yang, Junbao
    CANCER RESEARCH, 2020, 80 (16)
  • [6] Characterization of a novel class of RAS inhibitory compounds with potent anti-tumor activity
    Ward, Antonio
    Chen, Xi
    Valiyaveettil, Jacob
    Zhu, Bing
    Ramirez-Alcantara, Veronica
    Lee, Kevin J.
    Lindsey, Ashley
    Berry, Kristy
    Mattox, Tyler E.
    McConnell, Kate
    Boyd, Michael R.
    Piazza, Gary A.
    Keeton, Adam B.
    CANCER RESEARCH, 2017, 77
  • [7] Preclinical development of a novel oral multitargeted kinase inhibitor with potent in vivo anti-tumor activity
    Beaulieu, Normand
    Dupont, Isabelle
    Hannah Nguyen
    Carole, Beaulieu
    Ste-Croix, Helene
    Robert, Marie-France
    Lefebvre, Sylvain
    Lu, Ai Hua
    Dubay, Maria
    Rahil, Gabi
    Wang, James
    Mannion, Michael
    Raeppel, Stephane
    Saavedra, Oscar
    Claridge, Stephen
    Isakovic, Lubo
    Zhan, Lijie
    Gaudette, Frederic
    Zhou, Nancy
    Nantel, Miguel
    Raeppel, Franck
    Vaisburg, Arkadii
    Besterman, Jeffrey
    Maroun, Christiane
    CANCER RESEARCH, 2009, 69
  • [8] TTI-10001, a next generation small molecule STING agonist, demonstrates potent anti-tumor activity in mice following oral or intravenous administration
    Viller, Natasja Nielsen
    Dove, Peter
    Rosa, David
    Bossen, Bolette
    Tran Truong
    Mutukura, Tapfuma
    Jin, Debbie
    Charbonneau, Marilyse
    Brinen, Laura
    Dodge, Karen
    Lin, Gloria
    Winston, Jeff
    Uger, Robert
    Slassi, Malik
    Wang, Zezhou
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [9] Characterization of a novel anti-CD20 Stradobody™ with potent in vitro anti-tumor activity
    Zhang, Xiaoyu
    Burch, Erin
    Chen, Shaodong
    Sallin, Michelle
    Olsen, Henrik
    Block, David
    Strome, Scott
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [10] Tumor targeting of a STING agonist with an antibody-drug conjugate elicits potent anti-tumor immune responses
    Cetinbas, Naniye Malli
    Catcott, Kalli
    Avocetien, Kenneth
    Bentley, Keith
    Carter, Tyler
    Chin, Chen-Ni
    Clardy, Susan
    Eitas, Timothy
    Jones, Brian
    Kelleher, Eoin
    Mosher, Rebecca
    Nazzaro, Mark
    Nehilla, Barrett
    Protopopova, Marina
    Shaw, Pamela
    Slocum, Kelly
    Qin, LiuLiang
    Thomas, Josh
    Yang, Liping
    Toader, Dorin
    Damelin, Marc
    Duvall, Jeremy
    Bukhalid, Raghida
    Lowinger, Timothy
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
12345